By Jane Bentley, ICR Board Member & Vice President, Therapeutic Strategy and Innovation – Oncology at Syneos Health
Summary: Oncology clinical research is evolving beyond viewing patients as trial participants alone. Increasingly, patients are being recognised as valuable partners whose lived experiences can shape research design, improve trial outcomes and ensure studies reflect meaningful patient priorities.
Failing to incorporate patient perspectives can result in trials that overlook important quality-of-life considerations, create unnecessary barriers to participation and fail to address the needs of those they aim to help.
By embedding patient partnership throughout the clinical research lifecycle, the industry can develop more effective, inclusive and patient-focused oncology studies.
Why Is Patient Partnership in Oncology Clinical Research Becoming Essential?
Clinical research has always depended on patient participation, but the role of patients is changing. Rather than simply contributing data as study participants, patients are increasingly recognised as experts in their own experiences.
In oncology, where treatment decisions often involve complex choices, significant side effects and life-changing outcomes, patient insights provide valuable perspectives that cannot be gained through clinical data alone.
Patients can help researchers understand which outcomes matter most, identify practical challenges within trial designs and improve communication throughout the research journey.
Answer: Patient partnership in oncology clinical research ensures that trials are designed with patient experiences, priorities and real-world needs at the centre.
Meaningful patient involvement can improve recruitment, retention and overall study relevance while supporting research that is both scientifically robust and ethically aligned.
The Institute of Clinical Research (ICR) supports excellence in clinical research by promoting collaboration, education and professional development across the research community.
The Three Pillars of Patient Partnership in Oncology Clinical Research
Building meaningful patient involvement requires more than consultation. Successful partnerships are based on collaboration, transparency and shared decision-making.
1. Co-Creating More Relevant Clinical Trials
Patients bring unique insights into what it is actually like to live with a condition, undergo treatment and participate in research.
In oncology, this perspective is particularly valuable because treatment burden, quality of life and practical challenges can significantly influence a patient’s ability to take part in a trial. Engaging patients during protocol development can help researchers create studies with more realistic requirements, appropriate endpoints and outcomes that reflect what matters most to patients. Rather than designing research around patients, modern approaches focus on designing research with patients.
2. Strengthening Trust Through Transparency and Inclusion
Trust is essential in clinical research.
Patients and advocacy organisations increasingly expect transparency around how their contributions influence research decisions. Meaningful engagement requires clear communication, feedback loops and recognition of patient expertise.
Patient advocacy groups are also playing a growing role in ensuring research reflects diverse experiences and includes underrepresented communities. By creating more inclusive trial designs and improving communication, patient partnership helps strengthen confidence in the clinical research process.
3. Supporting Better Research Outcomes Through Collaboration
Patient involvement is not only ethically important, it can also improve the effectiveness of clinical studies.
When patient perspectives are considered early, researchers can identify barriers that may affect recruitment, retention and trial completion. Regulators, including the FDA, EMA and MHRA, increasingly support patient-focused approaches that incorporate patient experience data, patient-reported outcomes and meaningful involvement throughout development programmes. The future of oncology research depends on collaboration between patients, researchers, sponsors and healthcare professionals.
Key Patient Partnership in Oncology Clinical Research Considerations for Research Organisations
What factors help create meaningful patient involvement throughout clinical development?
| Patient Partnership Factor | Operational / Practical Impact | Core Benefit |
|---|---|---|
| Early Patient Involvement | Patients contribute insights during protocol and study design stages. | Creates trials that better reflect patient needs. |
| Patient-Reported Outcomes | Captures outcomes based on patient experiences and quality of life. | Provides a more complete understanding of treatment impact. |
| Transparent Communication | Ensures patients understand how their input influences decisions. | Builds trust and strengthens engagement. |
| Diversity and Inclusion | Encourages representation of different patient populations. | Supports more equitable and relevant research outcomes. |
Frequently Asked Questions
What does patient partnership mean in clinical research?
Patient partnership means involving patients as active collaborators throughout the research process, rather than only as participants in clinical trials. This can include contributing to study design, communication strategies and research priorities.
Why is patient involvement important in oncology trials?
Oncology trials often involve complex treatments and significant patient experiences. Patient involvement helps ensure studies consider quality of life, treatment burden and outcomes that are meaningful to those affected.
How are regulators supporting patient-focused research?
Regulators such as the FDA, EMA and MHRA increasingly encourage the use of patient experience data, patient-reported outcomes and patient input in clinical development and regulatory decision-making.
How can researchers improve patient engagement?
Researchers can improve engagement by involving patients early, providing appropriate support and training, recognising patient contributions and creating clear communication channels throughout the study lifecycle.
Partner with ICR for Advancing Patient Partnership in Clinical Research
The Institute of Clinical Research (ICR) is a membership organisation dedicated to developing clinical research professionals, promoting excellence and improving the quality and integrity of clinical trials for the benefit of patients.
Through education, collaboration and professional development, ICR supports the clinical research community in adopting approaches that improve trial delivery and patient outcomes.
As oncology research continues to evolve, the focus must move beyond patient participation towards genuine partnership. By embedding patient voices into research design and delivery, the industry can create studies that are scientifically strong, inclusive and truly centred around those they aim to serve.
Our Special Interest Groups (SIGs) bring ICR members together to explore important topics, exchange ideas and help shape valuable resources for the clinical research community.
SIG members are expected to actively participate and dedicate time to supporting the group’s activities and deliverables.
Interested in being part of a future Patients as Partners SIG? We’d love to hear from you. Contact office@ICR-global.org to find out more.
Read Next: Earlier Diagnosis, Smarter Recruitment — what struck me from Day 2 of the ICR Conference
Discover More: Unlocking the Future of Clinical Research: 5 Essential Insights into Decentralised Clinical Trials